Both of these U.S. dividend kings have increased payouts for over 50 consecutive years. The post RRSP Investors: Buy These ...

Biosimilars are safe, effective, and well-tolerated for psoriasis treatment, providing significant cost savings for the ...

Johnson & Johnson's innovative medicines division shows promise with expected revenues of $57bn by 2025. See more about JNJ ...

UCB SA has a promising drug, Bimzelx, despite temporary EBITDA decline and potential regulatory hurdles ahead. Learn more ...

Factors associated with increased flare rates post-vaccination included active disease at the time, female sex, and -- most ...

Ventyx Biosciences (NASDAQ:VTYX – Get Free Report)‘s stock had its “neutral” rating reiterated by equities research analysts at HC Wainwright in a research note issued to investors on Tuesday, ...

The Food and Drug Administration (FDA) has approved Imuldosa ™ (ustekinumab-srlf), a biosimilar to Stelara ® (ustekinumab), for the treatment of various chronic inflammatory diseases. Imuldosa, ...

Dr. Jonathan Hendrie is now accepting patients at the Lake Cumberland Rheumatology and Infusion Center of <a target=_blank href= ...

US President Joe Biden announced a $425 million arms package for Kyiv Wednesday in a call with President Volodymyr Zelensky, ahead of a farewell visit to Berlin to discuss Ukraine, the White House ...